cas 74853-07-9|| where to buy 2,4-dihydro-4-[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]-3H-1,2,4-triazol-3-one

Nombre del producto:2,4-dihydro-4-[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]-3H-1,2,4-triazol-3-one

IUPAC Name:4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one

Unidad de embalaje	Stock disponible	Precio($)
CM169541-1g	in stock	ƥŗ
CM169541-5g	in stock	ľƿƿ
CM169541-25g	in stock	ŹǪĲ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 74853-07-9 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :74853-07-9; Fórmula molecular:C19H21N5O2; Punto de fusión:-; Código de sonrisas:O=C1N(C2=CC=C(N3CCN(C4=CC=C(OC)C=C4)CC3)C=C2)C=NN1; Densidad:

: Número de catálogo:CM169541; Peso molecular:351.41; Punto de ebullición:; Nº Mdl:MFCD02956606; Almacenamiento:Store at 2-8°C.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.